Case report: Rare myeloid sarcoma development following renal transplantation with KRAS and DNMT3A gene mutations
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1746-1596
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Case report: Rare myeloid sarcoma development following renal transplantation with KRAS and DNMT3A gene mutations ; volume:16 ; number:1 ; day:31 ; month:8 ; year:2021 ; pages:1-5 ; date:12.2021
Diagnostic pathology ; 16, Heft 1 (31.8.2021), 1-5, 12.2021
- Urheber
-
Wu, Danyang
Lu, Xiaoxuan
Yan, Xiaojing
Gao, Ran
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13000-021-01141-z
- URN
-
urn:nbn:de:101:1-2021111406001995678610
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:36 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Wu, Danyang
- Lu, Xiaoxuan
- Yan, Xiaojing
- Gao, Ran
- SpringerLink (Online service)
Ähnliche Objekte (12)
DNMT3A mutations in chronic myeloid leukemia
Detection of DNMT3A R882 mutations in patients with acute myeloid leukaemia
DNMT3A mutations and clinical features in Chinese patients with acute myeloid leukemia
Mutations of neuroblastoma rat sarcoma (NRAS) and kirsten rat sarcoma (KRAS) in cutaneous T-cell lymphoma
Landscape of biallelic DNMT3A mutant myeloid neoplasms
Significance of targeting DNMT3A mutations in AML
DNMT3A mutations mediate the epigenetic reactivation of the leukemogenic factor MEIS1 in acute myeloid leukemia
Clinical features of De Novo acute myeloid leukemia with concurrent DNMT3A, FLT3 and NPM1 mutations
Gastric Myeloid Sarcoma
Mutations in DNMT3A, U2AF1, and EZH2 identify intermediate-risk acute myeloid leukemia patients with poor outcome after CR1
Hotspot DNMT3A mutations in clonal hematopoiesis and acute myeloid leukemia sensitize cells to azacytidine via viral mimicry response
Quantitative detection of DNMT3A R882H mutation in acute myeloid leukemia
DNMT3A mutations in chronic myeloid leukemia
Detection of DNMT3A R882 mutations in patients with acute myeloid leukaemia
DNMT3A mutations and clinical features in Chinese patients with acute myeloid leukemia
Mutations of neuroblastoma rat sarcoma (NRAS) and kirsten rat sarcoma (KRAS) in cutaneous T-cell lymphoma
Landscape of biallelic DNMT3A mutant myeloid neoplasms
Significance of targeting DNMT3A mutations in AML
DNMT3A mutations mediate the epigenetic reactivation of the leukemogenic factor MEIS1 in acute myeloid leukemia
Clinical features of De Novo acute myeloid leukemia with concurrent DNMT3A, FLT3 and NPM1 mutations
Gastric Myeloid Sarcoma
Mutations in DNMT3A, U2AF1, and EZH2 identify intermediate-risk acute myeloid leukemia patients with poor outcome after CR1
Hotspot DNMT3A mutations in clonal hematopoiesis and acute myeloid leukemia sensitize cells to azacytidine via viral mimicry response
Quantitative detection of DNMT3A R882H mutation in acute myeloid leukemia
DNMT3A mutations in chronic myeloid leukemia
Detection of DNMT3A R882 mutations in patients with acute myeloid leukaemia
DNMT3A mutations and clinical features in Chinese patients with acute myeloid leukemia
Mutations of neuroblastoma rat sarcoma (NRAS) and kirsten rat sarcoma (KRAS) in cutaneous T-cell lymphoma
Landscape of biallelic DNMT3A mutant myeloid neoplasms
Significance of targeting DNMT3A mutations in AML
DNMT3A mutations mediate the epigenetic reactivation of the leukemogenic factor MEIS1 in acute myeloid leukemia
Clinical features of De Novo acute myeloid leukemia with concurrent DNMT3A, FLT3 and NPM1 mutations
Gastric Myeloid Sarcoma
Mutations in DNMT3A, U2AF1, and EZH2 identify intermediate-risk acute myeloid leukemia patients with poor outcome after CR1
Hotspot DNMT3A mutations in clonal hematopoiesis and acute myeloid leukemia sensitize cells to azacytidine via viral mimicry response